259 related articles for article (PubMed ID: 805816)
1. Studies of the alternate pathway in chelated serum.
Forsgren A; Mclean RH; Michael AF; Quie PG
J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
[TBL] [Abstract][Full Text] [Related]
2. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
McLean RH; Townsend K; Michael AF
Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
[TBL] [Abstract][Full Text] [Related]
3. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
Des Prez RM; Bryan CS; Hawiger J; Colley DG
Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
[TBL] [Abstract][Full Text] [Related]
4. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
Inada K
Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
[TBL] [Abstract][Full Text] [Related]
5. Consumption of complement in chelated and nonchelated guinea pig serum after challenge with some viral and nonviral interferon inducers.
Rathová V; Kocisková D; Krizanová O; Borecký L
Acta Virol; 1976 Feb; 20(1):86-8. PubMed ID: 7949
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of activation of the properdin system. Studies on properdin electrophoretic mobility in agarose activation of the alternative pathway.
Adam C; Williams DG; Peters DK
Clin Exp Immunol; 1975 Nov; 22(2):240-8. PubMed ID: 813932
[TBL] [Abstract][Full Text] [Related]
7. C3 shunt activation in human serum chelated with EGTA.
Fine DP; Marney SR; Colley DG; Sergent JS; Des Prez RM
J Immunol; 1972 Oct; 109(4):807-9. PubMed ID: 4627510
[No Abstract] [Full Text] [Related]
8. The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum.
Hill AW; Shears AL; Hibbitt KG
Immunology; 1978 Jan; 34(1):131-6. PubMed ID: 75177
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function.
Fine DP
Infect Immun; 1977 Apr; 16(1):124-8. PubMed ID: 406201
[TBL] [Abstract][Full Text] [Related]
10. Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid.
Nakanishi K; Zbar B; Borsos T; Glenn G
Cancer Res; 1986 Aug; 46(8):3886-90. PubMed ID: 3089581
[TBL] [Abstract][Full Text] [Related]
11. Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia.
Kalwinsky DK; Urmson JR; Stitzel AE; Spitzer RE
J Lab Clin Med; 1976 Nov; 88(5):745-56. PubMed ID: 1068203
[TBL] [Abstract][Full Text] [Related]
12. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
Marney SR; Colley DG; Des Prez RM
J Immunol; 1975 Feb; 114(2 Pt 1):696-703. PubMed ID: 804512
[TBL] [Abstract][Full Text] [Related]
13. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
Ferrante A; Rowan-Kelly B
Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422
[TBL] [Abstract][Full Text] [Related]
14. Quantitative measurement of properdin in normal human serum by electroimmunoassay and single radial immunodiffusion.
Persson K; Kindmark CO; Pensky J; Naff G
Clin Exp Immunol; 1977 Jul; 29(1):84-8. PubMed ID: 408067
[TBL] [Abstract][Full Text] [Related]
15. Alternative complement pathway activity in sera from patients with sickle cell disease.
Koethe SM; Casper JT; Rodey GE
Clin Exp Immunol; 1976 Jan; 23(1):56-60. PubMed ID: 816581
[TBL] [Abstract][Full Text] [Related]
16. A properdin system intermediate formed by zymosan and serum at 0 degrees C.
Yukiyama Y; Lew FT; Waks HS; Osler AG
J Immunol; 1976 Jan; 116(1):188-93. PubMed ID: 812914
[TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
[No Abstract] [Full Text] [Related]
18. Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.
Ruley EJ; Forristal J; Davis NC; Andres C; West CD
J Clin Invest; 1973 Apr; 52(4):896-904. PubMed ID: 4693654
[TBL] [Abstract][Full Text] [Related]
19. Activation of murine complement by cobra venom factor in the presence of EDTA.
Goldman JN; Bangalore S; Goldman MB
J Immunol; 1979 Nov; 123(5):2421-7. PubMed ID: 114590
[No Abstract] [Full Text] [Related]
20. Complete absence of the third component of complement in man.
Ballow M; Shira JE; Harden L; Yang SY; Day NK
J Clin Invest; 1975 Sep; 56(3):703-10. PubMed ID: 1159084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
